Condition
Advanced Endometrial Carcinoma clinical trials and research
Research outlook What's coming for Endometrial cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 5 Advanced Endometrial Carcinoma clinical trials that are recruiting, at sites in 2 countries (most in United States (5), South Korea (1)). By phase: Phase 1 (3), Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 2Countries
Newest Advanced Endometrial Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Adding bevacizumab to carboplatin, paclitaxel and pembrolizumab for pMMR, TP53‑mutated advanced or recurrent endometrial cancer | Phase 3 | Birmingham, Alabama and 308 other locations | Recruiting | Sep 30, 2025 |
| Evaluating NKT3964 for Adults with Advanced Solid Tumors | Phase 1 | Little Rock, Arkansas and 20 other locations | Recruiting | Sep 19, 2024 |
| At-home cancer treatment versus clinic-based treatment for advanced cancer patients | Phase 2 | Jacksonville, Florida and 1 other locations | Recruiting | Aug 1, 2023 |
| Combining Tumor Treating Fields with Cabozantinib or Pembrolizumab and Nab-Paclitaxel for Advanced Solid Tumors | Phase 1 | Houston, Texas | Recruiting | Oct 25, 2021 |
| Treatment of advanced solid tumors with IACS-6274 and other medications | Phase 1 | Houston, Texas | Recruiting | Sep 10, 2021 |
All recruiting trials (5)
-
Adding bevacizumab to carboplatin, paclitaxel and pembrolizumab for pMMR, TP53‑mutated advanced or recurrent endometrial cancer
This trial tests whether adding bevacizumab to carboplatin and paclitaxel with pembrolizumab helps people with pMMR, TP53‑mutated advanced or recurrent endometrial cancer live longer without the disease getting worse.
-
Evaluating NKT3964 for Adults with Advanced Solid Tumors
This study is testing a new drug called NKT3964 to see if it can safely help adults with advanced solid tumors, like ovarian or triple-negative breast cancer, after other treatments have failed.
-
At-home cancer treatment versus clinic-based treatment for advanced cancer patients
This study tests whether giving cancer treatment at home is better for comfort and satisfaction compared to getting it at a clinic for people with advanced cancer.
-
Combining Tumor Treating Fields with Cabozantinib or Pembrolizumab and Nab-Paclitaxel for Advanced Solid Tumors
This study is testing a new treatment that combines tumor treating fields with two different cancer drugs to see if it helps people with advanced solid tumors in the abdomen or chest.
-
Treatment of advanced solid tumors with IACS-6274 and other medications
This study is testing a new drug called IACS-6274, alone and with other medications, to see how well it can help people with advanced solid tumors and what the safest dose is.
Related topics
Quick answers
How many Advanced Endometrial Carcinoma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (5 trials), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.